Our drug policy prioritizes eliminating rare disease. Is that the right goal?

Our drug policy prioritizes eliminating rare disease. Is that the right goal?

STAT Plus: Our drug policy often prioritizes eliminating rare disease. One researcher asks: Is that the right goal?

By NICHOLAS FLORKO

EMILIE PICKERING FOR STAT

Peter Bach is suggesting the incentives created by policymakers to improve public health aren’t the best ideas for achieving that overarching goal.

READ MORE